Hormonal responses to fasting and refeeding in chronic renal failure patients

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 1 51-1, 2005, Pages

  Deshmukh, Sonali ^a   Phillips, Bradley G ^b   O'Dorisio, Thomas ^a   Flanigan, Michael J ^a   Lim, Victoria S ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Appetite; Hormones; Uremia

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; LEPTIN; NEUROPEPTIDE Y;

ADULT; APPETITE; ARTICLE; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOOD DEPRIVATION; FOOD INTAKE; GROWTH HORMONE RELEASE; HORMONE RESPONSE; HUMAN; INSULIN BLOOD LEVEL; MALE; MALNUTRITION; POSITIVE FEEDBACK; PRIORITY JOURNAL; REFEEDING; SATIETY; UREMIA;

ADRENOCORTICOTROPIC HORMONE; ADULT; APPETITE; BLOOD GLUCOSE; EATING; FASTING; FEMALE; HUMANS; HYDROCORTISONE; INSULIN; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; NEUROPEPTIDE Y;

EID: 11144347773     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00163.2004     Document Type: Article

References (38)

1. Akabayashi A, Levin N, Paez X, Alexander JT, and Leibowitz SF. Hypothalamic neuropeptide Y and its gene expression: relation to light/dark cycle and circulating corticosterone. Mol Cell Neurosci 5: 210-218, 1994.
2. 3-36 physiologically inhibits food intake. Nature 418: 650-654, 2002.
3. Bergstrom J. Why are dialysis patients malnourished? Am J Kidney Dis 26: 229-241, 1995.
4. Billington CJ, Briggs JE, Grace M, and Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol Regul Integr Comp Physiol 260: R321-R327, 1991.
5. Brady LS, Smith MA, Gold PW, and Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52: 441-447, 1990.
6. Chambers J, Ames RS, Bergsma D, Muir A, Fitzgerald LR, Hervieu G, Dytko GM, Foley JJ, Martin J, Liu WS, Park J, Ellis C, Ganguly S, Konchar S, Cluderay J, Leslie R, Wilson S, and Sarau HM. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 400: 261-264, 1999.
7. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, and Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327: 1912-1918, 1992.
8. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, and Jeejeebhoy KN. What is subjective global assessment of nutritional status? J Parenter Enteral Nutr 11: 8-13, 1987.
9. Erickson JC, Clegg KE, and Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381: 415-418, 1996.
10. Fan W, Boston BA, Kesterson RA, Hruby VJ, and Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168, 1997.
11. Friedman JM and Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
12. Gardner JD, Rothwell NJ, and Luheshi GN. Leptin affects food intake via CRF-receptor-mediated pathways. Nat Neurosci 1: 103, 1998.
13. Heimburger O, Lonnqvist F, Danielsson A, Nordenstrom J, and Stenvinkel P. Serum immunoreactiVe leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8: 1423-1430, 1997.
14. Ikizler TA, Greene JH, Wingarij RL, Parker RA, and Hakim RM. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6: 1386-1391, 1995.
15. Katz AI and Rubenstein AH. Metabolim of proinsulin, insulin, and C-peptidein the rat. J Clin Invest 52: 1113-1121, 1973.
16. Klein S, Horowitz JF, Landt M, Goodrick SJ, Mohamed-Ali V, and Coppack SW. Leptin production during early starvation in lean and obese women. Am J Physiol Endocrinol Metab 278: E280-E284, 2000.
17. Krukoff TL. NPY-containing nerve terminals and fibers in close association with peptidergic sympathetic preganglionic neurons. Neurosci Lett 77: 1-4, 1987.
18. Lim VS and Flanigan MJ. Organ and metabolic complications-abnormal endocrine function in chronic renal failure. In: Replacement of Renal Function by Dialysis (4th ed.), edited by Jacobs C, Kjellstrand CM, Koch KM, and Winchester JF. London: Kluwer Academic, 1996, p. 1236-1242.
19. Lim VS, Yarasheski KE, Crowley JR, Fangman J, and Flanigan MJ. Insulin is protein-anabolic in chronic renal failure patients. J Am Soc Nephrol 14: 2297-2304, 2003.
20. Lim VS, Yarasheski KE, and Flanigan MJ. The effect of uraemia, acidosis, and dialysis treatment on protein metabolism: a longitudinal leucine kinetic study. Nephrol Dial Transplant 13: 1723-1730, 1998.
21. Maack T, Johnson V, Kau ST, Figueiredo J, and Sigulem D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 16: 251-270, 1979.
22. Marks DL, Ling N, and Cone RD. Role of the central melanocortin system in cachexia. Cancer Res 61: 1432-1438, 2001.
23. Morris MJ, Cox HS, Lambert GW, Kaye DM, Jennings GL, Meredith IT, and Esler MD. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension 29: 137-143, 1997.
24. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, and Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409: 194-198, 2001.
25. Pedrazzini T, Seydoux J, Kunstner P, Aubert JF, Grouzmann E, Beermann F, and Brunner HR. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 4: 722-726, 1998.
26. Pratley JRE, Nicolson M, Bogardus C, and Ravussin E. Plasma leptin responses to fasting in Pima Indians. Am J Physiol Endocrinol Metab 273: E644-E649, 1997.
27. Raben A, Tagliabue A, and Astrup A. The reproducibility of subjective appetite scores. Br J Nutr 73: 517-530, 1995.
28. Sahu A, Kalra PS, and Kalra SP. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 9: 83-86, 1988.
29. Sainsbury A, Cusin I, Rohner-Jeanrenaud F, and Jeanrenaud B. Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes 46: 209-214, 1997.
30. Sainsbury A, Rohher-Jeanrenaud F, Grouzmann E, and Jeanrenaud B. Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats. Neuroendocrinology 63: 318-326, 1996.
31. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, William SC, Richardson JA, Kozlowski GP, Wilson S, Arch JRS, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshpurbagy NA, Bergsma DJ, and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
32. Saladin R, DeVos P, Guerre-Millo M, Leturque J, Girard B, Staels B, and Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature 377: 527-529, 1995.
33. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewicz DP, and Porte D JR. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130: 3608-3616, 1992.
34. Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, Kurnik BRC, Kurnik PB, O'Connor J, Sinha M, and Caro JF. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51: 1980-1985, 1997.
35. Sievertsen GD, Lim VS, Nakawatase C, and Frohman LA. Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. J Clin Endocrinol Metab 50: 846-852, 1980.
36. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, and Carp JF. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 97: 1344-1347, 1996.
37. Strack AM, Sebastian RJ, Schwartz MW, and Dallman MF. Glucocorticoids and insulin: reciprocal signals for energy balance. Am J Physiol Regul Integr Comp Physiol 268: R142-R149, 1995.
38. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Parlongo S, Cutrupi S, Iellamo D, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, and Malatino LS. Prospective study of neuropeptide Y as an adverse cardiovascular risk factor in end-stage renal disease. J Am Soc Nephrol 14: 2611-2617, 2003.